John A. Gans, PharmD, Executive Vice President and Chief Executive Officer for the American Pharmacists Association (APhA) has been selected as a recipient of the Food and Drug Administration"s (FDA) Commissioner"s Special Citation Award. The award will be bestowed upon Dr. Gans today during a ceremony at Martin"s Crosswinds, Greenbelt, Maryland.
generic viagra online
Mylan Inc. (Nasdaq: MYL) announced that its subsidiary Mylan Pharmaceuticals Inc. has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Bicalutamide Tablets, 50 mg.
Siemens Corporate Research (SCR), Inc. announced that it developed the RAPID2 system to speed the biomarker discovery process for the development of rapid diagnostic tests. This system marries the power of information technology with today"s improved genomic sequencing to quickly identify genomic signatures unique to the set of organisms to be detected. These signatures are the foundation for a new generation of molecular diagnostic tests for the rapid detection of healthcare-associated
infections such as the potentially deadly Methicillin-Resistant Staphylococcus Aureus (MRSA). Gayle Wittenberg, Program Manager at Siemens Corporate Research"s Princeton, New Jersey-based research and development center, along with her Princeton and Erlangen, Germany colleagues, have been utilizing complex information technology models to focus on genetic targets that quickly identify pathogenic bacteria. contactos
Leaders in biotechnology research and patient advocacy joined forces today at the 2009 BIO International Convention to discuss the latest breakthroughs in HIV/AIDS treatments. Following a keynote speech by Sir Elton John focused on the needs of the HIV/AIDS community, representatives of biotech companies previewed the next generation of treatments while patient advocates reiterated the need for new therapies, particularly for those who have developed resistance to existing
medications. Researchers are developing new therapies that are more effective in treating HIV/AIDS, including an AIDS vaccine and new methods of delivery that hold the potential to increase patient compliance. "Through biotechnology, we have been able to suppress many of the symptoms of AIDS, increasing both quality of life and life expectancy for millions of people around the world who are living with HIV/AIDS.
Timberline Knolls, one of the country"s leaders in the treatment of eating disorders, is recognizing well-known tennis star, Monica Seles, for disclosing her history with an eating disorder in her new book Get a Grip. Ms. Seles" display of courage and candor has the potential to help many others who have similar struggles, especially young female athletes. It is estimated that more than 11 million Americans suffer from an eating disorder and 20 million more suffer
from binge-eating disorder. And because of the secretiveness and shame associated with eating disorders, this number is likely much larger. According to Kimberly Dennis, M.D., medical director at Timberline Knolls, the prevalence eating disorders in female athletes occur at an even higher rate than the general population.
Researchers from CIC bioGUNE"s Structural Biology Unit and Columbia University (New York) have conducted a joint research project, published in the prestigious scientific journal Structure, to gain in-depth knowledge of the structure of pyruvate carboxylase when it is in solution (in the "natural" state). Pyruvate carboxylase is a metabolic enzyme that plays a fundamental role in the metabolism of fatty acids (the components of fats) and sugars. When its function
is not adequately performed (for example, when mutations in the gene arise) diverse metabolic diseases of genetic origin are triggered, amongst them lactic acidaemia, hypoglycaemia, and psycho-motor retardation.
Siemens Corporate Research (SCR), Inc. announced that it developed the RAPID2 system to speed the biomarker discovery process for the development of rapid diagnostic tests. This system marries the power of information technology with today"s improved genomic sequencing to quickly identify genomic signatures unique to the set of organisms to be detected. These signatures are the foundation for a new generation of molecular diagnostic tests for the rapid detection of healthcare-associated
infections such as the potentially deadly Methicillin-Resistant Staphylococcus Aureus (MRSA). Gayle Wittenberg, Program Manager at Siemens Corporate Research"s Princeton, New Jersey-based research and development center, along with her Princeton and Erlangen, Germany colleagues, have been utilizing complex information technology models to focus on genetic targets that quickly identify pathogenic bacteria. 
Leaders in biotechnology research and patient advocacy joined forces today at the 2009 BIO International Convention to discuss the latest breakthroughs in HIV/AIDS treatments. Following a keynote speech by Sir Elton John focused on the needs of the HIV/AIDS community, representatives of biotech companies previewed the next generation of treatments while patient advocates reiterated the need for new therapies, particularly for those who have developed resistance to existing
medications. Researchers are developing new therapies that are more effective in treating HIV/AIDS, including an AIDS vaccine and new methods of delivery that hold the potential to increase patient compliance. "Through biotechnology, we have been able to suppress many of the symptoms of AIDS, increasing both quality of life and life expectancy for millions of people around the world who are living with HIV/AIDS. 
Timberline Knolls, one of the country"s leaders in the treatment of eating disorders, is recognizing well-known tennis star, Monica Seles, for disclosing her history with an eating disorder in her new book Get a Grip. Ms. Seles" display of courage and candor has the potential to help many others who have similar struggles, especially young female athletes. It is estimated that more than 11 million Americans suffer from an eating disorder and 20 million more suffer
from binge-eating disorder. And because of the secretiveness and shame associated with eating disorders, this number is likely much larger. According to Kimberly Dennis, M.D., medical director at Timberline Knolls, the prevalence eating disorders in female athletes occur at an even higher rate than the general population. 
Researchers from CIC bioGUNE"s Structural Biology Unit and Columbia University (New York) have conducted a joint research project, published in the prestigious scientific journal Structure, to gain in-depth knowledge of the structure of pyruvate carboxylase when it is in solution (in the "natural" state). Pyruvate carboxylase is a metabolic enzyme that plays a fundamental role in the metabolism of fatty acids (the components of fats) and sugars. When its function
is not adequately performed (for example, when mutations in the gene arise) diverse metabolic diseases of genetic origin are triggered, amongst them lactic acidaemia, hypoglycaemia, and psycho-motor retardation.